The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
A placebo—verum difference in antidepressant response of at least three points on the Hamilton Depression Rating Scale has been proposed as the threshold for clinical significance in antidepressant trials. Given the considerable clinical and regulatory consequences of such a definition of clinical relevance it deserves a critical discussion. Eight arguments are presented indicating that using this definition as a criterion for assessing the clinical utility of antidepressants in daily practice would risk erroneously discarding treatments with a clear benefit for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 2×
“(2) The placebo effect in antidepressant RCTs has increased in the last decades and is around 30% (Walsh et al., 2002).”
BackgroundRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“The mean rate of relapse on placebo was 41%, as compared with 18% on antidepressant drugs (Geddes et al., 2003).”
BackgroundMaintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476
Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406 · cited 2×
“(Szegedi et al., 2003; Papakostas et al., 2006; Taylor et al., 2006; Stassen et al., 2007; Henkel et al., 2008; van Calker et al., 2009a; Tadić et al., 2009).”
BackgroundSneed, J. R., Rutherford, B. R., Rindskopf, D., Lane, D. T., Sackeim, H. A., & Roose, S. P. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181256b1d · Cited by 140 · cited 1×
“The size of this effect is likely to be relevant as Sneed et al. (2008) reported that antidepressant response rates in trials with two active drugs (comparative trials) were on average 60%, but only 46% in placebo-controlled trials.”
BackgroundUncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123 · cited 1×
“This should be obvious because of difficulties in defining a control group and in blinding therapists as well as patients (e.g. Nutt and Sharpe, 2008).”
Background
Cited by
Kramer, I., Simons, C. J. P., Hartmann, J. A., Menne-Lothmann, C., Viechtbauer, W., Peeters, F., Schruers, K., van Bemmel, A. L., Myin-Germeys, I., Delespaul, P., et al. (2014) · World Psychiatry · doi:10.1002/wps.20090 · Cited by 306
“Power calculations using the STATA (30) SAMPSI command were based on previous work (33), and led to an initial sample size of 120 with a power of 84% to detect a 3-point difference in HDRS score (31,32).”
BackgroundMethodResultMergl, R., Henkel, V., Allgaier, A.-K., Kramer, D., Hautzinger, M., Kohnen, R., Coyne, J., & Hegerl, U. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000318772 · Cited by 126
“Furthermore, there are convincing arguments that the benefit of antidepressants in mild depression is considerably larger than that suggested by placebo/active treatment differences in clinical trials [”
BackgroundSelf-citationHartmann, J. A., Wichers, M., Menne-Lothmann, C., Kramer, I., Viechtbauer, W., Peeters, F., Schruers, K. R. J., van Bemmel, A. L., Myin-Germeys, I., Delespaul, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128095 · Cited by 62
“Power calculations using the STATA SAMPSI command were based on previous work [27], and led to an initial sample size of 120 with a power of 84% to detect a 3-point difference in the score on the 17-item Hamilton Depression Rating Scale (HDRS, [22]) [28, 29], the main outcome as reported in the previous study [20].”
MethodCuijpers, P., Karyotaki, E., Andersson, G., Li, J., Mergl, R., & Hegerl, U. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.06.005 · Cited by 44
“In trials comparing psychotherapy to control conditions, patients randomized to psychotherapy typically know whether they have been randomized to the psychotherapeutic intervention or to the control condition, and the same is true for the treating therapists [26,28,54].”
BackgroundSelf-citation
Metadata
- Authors
- Hegerl, U., & Mergl, R.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2009-10-13
- Volume
- 24
- Issue
- 4
- Pages
- 445-448
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2091591566
- Cited by
- 56
- References
- 7
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. https://app.cochat.ai/papers/10.1177/0269881109106930
- The paper
- Hegerl, U., & Mergl, R. (2010). The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. Journal of Psychopharmacology. https://doi.org/10.1177/0269881109106930
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.